This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version    RSS    Subscribe    Unsubscribe    Archive    Media Kit           June 24, 2015

Home     About SGO    Education    Membership    Clinical Practice    Public Policy    Blog    Partnerships    Store



HPV
 

Cancer doctors offer way to compare medicines, including by cost
The New York Times (Subscription required)
Alarmed by the rapid escalation in the price of cancer drugs, the nation’s leading oncology society unveiled a new way for doctors and patients to evaluate different treatments — one that pointedly includes a medicine’s cost as well as its effectiveness and side effects.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




How much should cancer drugs cost?
The Wall Street Journal (Subscription required)
One of the nation’s top cancer hospitals is challenging the pharmaceutical industry to adopt a more rational approach to drug pricing. Memorial Sloan Kettering Cancer Center in New York has created an interactive calculator that compares the cost of more than 50 cancer drugs with what the prices would be if they were tied to factors such as the side effects the drugs produce, and the amount of extra life they give patients. In many cases, the website calculates a price that is lower than the drug’s market price.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


SGO NEWS


Update SGO member status by July 31
Are you graduating from your Fellowship program? Starting your residency? Ensure you update your membership status so you can continue to receive all of your valuable SGO benefits. Transitioning SGO members need to update their member status by Friday, July 31. Online application forms for all eight membership levels are available on sgo.org.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Advertisement
PRODUCT SHOWCASE
  ChemoFx Improves Ovarian Cancer Outcomes
ChemoFx® provides invaluable information to physicians choosing from 20+ equivalent treatment recommendations without prior knowledge of how individual patients may respond. ChemoFx determines platinum resistance in primary ovarian cancer and demonstrates longer overall survival by 14 months in recurrent ovarian cancer, making it instrumental in improving patient outcomes.
 


TUBAL LIGATION


Tubal ligation cuts risk of aggressive endometrial cancer
MedPage Today
Women who undergo tubal ligation (TL) at young ages and develop aggressive endometrial carcinoma later in life present with lower-stage disease and have a lower rate of mortality than do women who have not undergone TL, the NRG Oncology/Gynecologic Oncology Group 210 Trial has revealed in the Journal of the National Cancer Institute.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Do tubal ligation and salpingectomy protect against ovarian cancer?
Medscape (Free login required)
The authors of this case-control study have found a significantly lower risk for ovarian cancer among those with tubal ligation or bilateral salpingectomy. The risk differed according to the histologic type. The various mechanisms leading to the certain histologic types of ovarian cancer can explain the findings. With tubal disruption, endometrial cell, carcinogen chemicals, and infectious agents cannot reach the ovary. According to this study, the risk for endometrioid ovarian cancer was reduced by 50% among those who had tubal ligation before the age of 35 years.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


HEALTH POLICY


Many physicians still unprepared for ICD-10
Medscape (Free login required)
With less than 4 months to go before the Oct. 1, 2015, transition to the International Classification of Diseases (ICD)-10 diagnostic coding, many hospitals and physician practices have taken many of the necessary steps toward implementation, but still lag behind in a crucial part of the process — testing.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




CERVICAL CANCER


Study finds decreased rates of high-grade cervical lesions in young women
Medical Xpress
A new analysis indicates that rates of high-grade cervical lesions decreased in young U.S. women after vaccines were made available to protect against human papillomavirus (HPV), but the trend may be due in part to changes in cervical cancer screening recommendations. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study illustrates some of the challenges in monitoring a vaccine's impact during a time of concurrent changes in screening.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


MISSED AN ISSUE OF WOMEN'S CANCER NEWS?
Visit the SGO Women's Cancer News archive page.


It's time to pay attention to 'below-the-belt' cancers
NPR
When an email arrived the other day promoting an "Interfaith Service Focused on Below the Belt Cancers," I was intrigued. It turns out Thursday, June 18, is the start of the third "Globe-athon to End Women's Cancers." To kickoff this continuing campaign, there were two days of events in New York City dedicated to making people more aware of the cancers that strike more than 1 million women a year and figuring out the best strategies for diagnosis and treatment. To learn more, I spoke with Dr. Larry Maxwell, founder of the Globe-athon and a gynecological oncologist at Inova Fairfax Hospital in Virginia.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


 



Women's Cancer News
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Jessica Taylor, Senior Medical Editor, 202-684-7169  
Contribute news


Inclusion of advertisements does not constitute SGO endorsement of company products or services.

Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of the Women's Cancer News was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!

Recent issues

June 17, 2015
June 10, 2015
June 3, 2015
May 27, 2015






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063